Published in AIDS Care on April 01, 2007
Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr (2009) 3.88
A recent perspective on alcohol, immunity, and host defense. Alcohol Clin Exp Res (2008) 2.50
A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend (2010) 2.38
A pandemic of the poor: social disadvantage and the U.S. HIV epidemic. Am Psychol (2013) 2.27
Alcohol use and sex risk behaviors among HIV-infected female sex workers (FSWs) and HIV-infected male clients of FSWs in India. AIDS Behav (2010) 1.62
Quality of HIV Care and Mortality Rates in HIV-Infected Patients. Clin Infect Dis (2015) 1.42
Integrating HIV/AIDS and alcohol research. Alcohol Res Health (2010) 1.36
The temporal relationship between alcohol consumption and HIV-medication adherence: a multilevel model of direct and moderating effects. Health Psychol (2008) 1.27
Adjusting alcohol quantity for mean consumption and intoxication threshold improves prediction of nonadherence in HIV patients and HIV-negative controls. Alcohol Clin Exp Res (2008) 1.23
Alcohol use and non-adherence to antiretroviral therapy in HIV-infected patients in West Africa. Addiction (2010) 1.17
Integrated Management of Physician-delivered Alcohol Care for Tuberculosis Patients: Design and Implementation. Alcohol Clin Exp Res (2009) 1.12
Use of and Adherence to Antiretroviral Therapy in a Large U.S. Sample of HIV-infected Adults in Care, 2007-2008. Open AIDS J (2012) 1.11
HIV infection, aging, and immune function: implications for cancer risk and prevention. Curr Opin Oncol (2012) 1.10
Reductions in alcohol and cocaine use following a group coping intervention for HIV-positive adults with childhood sexual abuse histories. Addiction (2010) 1.08
Influence of alcohol consumption on adherence to and toxicity of antiretroviral therapy and survival. Alcohol Res Health (2010) 1.08
Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival. J Womens Health (Larchmt) (2011) 1.07
HIV-1 transgene expression in rats causes oxidant stress and alveolar epithelial barrier dysfunction. AIDS Res Ther (2009) 1.05
HIV/AIDS, comorbidity, and alcohol: can we make a difference? Alcohol Res Health (2010) 1.02
Association between alcohol use and HIV viral load. J Acquir Immune Defic Syndr (2011) 0.99
Untreated HIV infection is associated with higher blood alcohol levels. J Acquir Immune Defic Syndr (2012) 0.96
Chronic alcohol ingestion exacerbates lung epithelial barrier dysfunction in HIV-1 transgenic rats. Alcohol Clin Exp Res (2011) 0.95
Alcohol Consumption, Progression of Disease and Other Comorbidities, and Responses to Antiretroviral Medication in People Living with HIV. AIDS Res Treat (2012) 0.94
Focus on the heart: alcohol consumption, HIV infection, and cardiovascular disease. Alcohol Res Health (2010) 0.91
Interactions between alcohol and the antiretroviral medications ritonavir or efavirenz. J Addict Med (2013) 0.86
Development of an electronic medical record-based clinical decision support tool to improve HIV symptom management. AIDS Patient Care STDS (2009) 0.86
Risk behaviors among HIV-positive gay and bisexual men at party-oriented vacations. J Stud Alcohol Drugs (2013) 0.85
HealthCall for the smartphone: technology enhancement of brief intervention in HIV alcohol dependent patients. Addict Sci Clin Pract (2014) 0.85
Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections. World J Hepatol (2016) 0.85
Unhealthy substance-use behaviors as symptom-related self-care in persons with HIV/AIDS. Nurs Health Sci (2011) 0.85
Number of Drinks to "Feel a Buzz" by HIV Status and Viral Load in Men. AIDS Behav (2016) 0.84
Chronic binge alcohol consumption does not diminish effectiveness of continuous antiretroviral suppression of viral load in simian immunodeficiency virus-infected macaques. Alcohol Clin Exp Res (2014) 0.83
Alcohol use and its association with HIV risk behaviors among a cohort of patients attending HIV clinical care in Tanzania, Kenya, and Namibia. AIDS Care (2014) 0.83
Alcohol use disorders and associated factors among people living with HIV who are attending services in south west Ethiopia. BMC Res Notes (2014) 0.83
Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances. Neurobehav HIV Med (2012) 0.80
Self-reevaluation as a critical component in sustained viral load change for HIV+ adults with alcohol problems. Ann Behav Med (2010) 0.80
Alcohol and HIV Effects on the Immune System. Alcohol Res (2015) 0.80
Heavy Alcohol Use Is Associated With Worse Retention in HIV Care. J Acquir Immune Defic Syndr (2016) 0.80
Effects of combined alcohol and anti-HIV drugs on cellular stress responses in primary hepatocytes and hepatic stellate and kupffer cells. Alcohol Clin Exp Res (2015) 0.79
Efficacy of an alcohol-focused intervention for improving adherence to antiretroviral therapy (ART) and HIV treatment outcomes - a randomised controlled trial protocol. BMC Infect Dis (2014) 0.79
Impact of immunodepression and moderate alcohol consumption on coronary and other arterial disease events in an 11-year cohort of HIV-infected patients on antiretroviral therapy. BMJ Open (2012) 0.79
Measuring alcohol consumption using Timeline Followback in non-treatment-seeking medical clinic patients with and without HIV infection: 7-, 14-, or 30-day recall. J Stud Alcohol Drugs (2013) 0.79
Rate and predictors of employment among formerly polysubstance dependent urban individuals in recovery. J Addict Dis (2012) 0.79
Chronic Binge Alcohol Administration Increases Intestinal T-Cell Proliferation and Turnover in Rhesus Macaques. Alcohol Clin Exp Res (2015) 0.77
Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment. AIDS Behav (2017) 0.76
Alcohol and associated characteristics among older persons living with human immunodeficiency virus on antiretroviral therapy. Subst Abus (2014) 0.76
The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular Events. J Acquir Immune Defic Syndr (2016) 0.76
Task-shifting alcohol interventions for HIV+ persons in Kenya: a cost-benefit analysis. BMC Health Serv Res (2017) 0.75
Interaction of disulfiram with antiretroviral medications: efavirenz increases while atazanavir decreases disulfiram effect on enzymes of alcohol metabolism. Am J Addict (2013) 0.75
Decreased injecting is associated with increased alcohol consumption among injecting drug users in northern Vietnam. Int J Drug Policy (2013) 0.75
Perceived health and alcohol use in individuals with HIV and Hepatitis C who use drugs. Addict Behav (2017) 0.75
A cluster randomised controlled trial protocol of an adapted intervention for alcohol use disorders in people living with HIV and AIDS: impact on alcohol use, general functional ability, quality of life and adherence to HAART. BMC Psychiatry (2017) 0.75
HIV Treatment in Resource-Limited Environments: Treatment Coverage and Insights. Value Health (2015) 0.75
Feasibility and Acceptability of a Smartphone App for Daily Reports of Substance Use and Antiretroviral Therapy Adherence among HIV-Infected Adults. AIDS Res Treat (2016) 0.75
Effect of alcohol consumption on all-cause and liver-related mortality among HIV-infected individuals. HIV Med (2016) 0.75
Immune activation and neuroinflammation in alcohol use and HIV infection: evidence for shared mechanisms. Am J Drug Alcohol Abuse (2016) 0.75
Optimal Treatment Adherence Counseling Outcomes for People Living with HIV and Limited Health Literacy. Behav Med (2014) 0.75
HIV and Alcohol Research Priorities of City, State, and Federal Policymakers: Results of a Delphi Study. Am J Public Health (2015) 0.75
Clinicopathologic Features of Colorectal Carcinoma in HIV-Positive Patients. Cancer Epidemiol Biomarkers Prev (2016) 0.75
Comparison of AUDIT-C collected via electronic medical record and self-administered research survey in HIV infected and uninfected patients. Drug Alcohol Depend (2016) 0.75
Alcohol Use, HIV Treatment Adherence, and Sexual Risk Among People with a History of Injecting Drug Use in Vietnam. AIDS Behav (2017) 0.75
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med (2000) 23.10
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet (2002) 16.56
Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25
HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health (2001) 6.29
The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med (2001) 5.89
Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis (2001) 5.43
Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med (2002) 5.30
Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med (2002) 4.77
A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med (2002) 4.49
Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med (2003) 3.81
Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS (2002) 3.45
Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet (1999) 3.41
A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS (2002) 3.41
A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res (2005) 3.21
Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS (1998) 3.16
Benefit-cost analysis of brief physician advice with problem drinkers in primary care settings. Med Care (2000) 3.08
Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med (2001) 2.81
Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (2001) 2.51
Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med (2005) 2.38
A conceptual framework of frailty: a review. J Gerontol A Biol Sci Med Sci (2002) 2.38
HIV and hepatitis C virus co-infection. Lancet Infect Dis (2004) 2.35
Alcohol consumption and HIV disease progression: are they related? Alcohol Clin Exp Res (2003) 2.32
The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. Arch Intern Med (2005) 1.97
Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med (1997) 1.58
Alcohol use and sexual risk behavior among human immunodeficiency virus-positive persons. Alcohol Clin Exp Res (2005) 1.48
Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J Am Coll Cardiol (2000) 1.34
Cost-effectiveness analysis of a brief intervention delivered to problem drinkers presenting at an inner-city hospital emergency department. J Stud Alcohol (2004) 1.29
Estimating the rate of accumulating drug resistance mutations in the HIV genome. Value Health (2007) 1.26
Impact of adherence to antiretroviral therapy in HIV-1-infected patients at a university public service in Brazil. AIDS Patient Care STDS (2001) 1.24
Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort. AIDS Res Hum Retroviruses (1999) 1.22
Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 1.17
Brief physician advice for problem drinking among older adults: an economic analysis of costs and benefits. J Stud Alcohol (2005) 1.15
Antiretroviral-associated liver injury. Clin Liver Dis (2003) 0.97
Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders? Bioessays (2001) 0.81
Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system. N Engl J Med (1993) 6.09
beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci (1992) 4.10
The cost-effectiveness of sildenafil. Ann Intern Med (2000) 3.62
Development and validation of a self-completed HIV symptom index. J Clin Epidemiol (2001) 3.28
Inquiry about victimization experiences. A survey of patient preferences and physician practices. Arch Intern Med (1992) 3.11
Complete genome sequence of Vibrio fischeri: a symbiotic bacterium with pathogenic congeners. Proc Natl Acad Sci U S A (2005) 3.05
Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. JAMA (1994) 2.83
Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med (2001) 2.81
Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer. Gene Ther (2001) 2.69
Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut (2009) 2.62
Three questions can detect hazardous drinkers. J Fam Pract (2001) 2.53
Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med (2009) 2.48
Patients, payers, and paradigm shifts: what to do about Helicobacter pylori. Am J Gastroenterol (1996) 2.43
Measuring prognosis and case mix in hospitalized elders. The importance of functional status. J Gen Intern Med (1997) 2.42
When doctors marry doctors: a survey exploring the professional and family lives of young physicians. Ann Intern Med (1999) 2.37
Systemic absorption of sunscreen after topical application. Lancet (1997) 2.36
Stereotactic targeting of the globus pallidus internus in Parkinson's disease: imaging versus electrophysiological mapping. Neurosurgery (1999) 2.13
Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. J Clin Epidemiol (2001) 2.09
Relationship of cerebral intraventricular hemorrhage and early childhood neurologic handicaps. J Pediatr (1983) 2.05
Serious complications with neck manipulation and informed consent. Med J Aust (2000) 2.01
In Vitro Binding of Agrobacterium tumefaciens to Plant Cells from Suspension Culture. Plant Physiol (1979) 2.01
The log-linear relationship between sexual isolation and sequence divergence in Bacillus transformation is robust. Genetics (1995) 2.00
Do patient preferences contribute to racial differences in cardiovascular procedure use? J Gen Intern Med (1997) 1.91
Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature (1993) 1.85
Unsustained multiplication of treponema pallidum (nichols virulent strain) in vitro in the presence of oxygen. Infect Immun (1978) 1.80
Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group. J Acquir Immune Defic Syndr (1999) 1.74
Nucleosome positioning on the MMTV LTR results from the frequency-biased occupancy of multiple frames. Genes Dev (1995) 1.74
Simultaneous degradation of alphaII- and betaII-spectrin by caspase 3 (CPP32) in apoptotic cells. J Biol Chem (1998) 1.72
Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation. J Antimicrob Chemother (2006) 1.70
General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era. J Clin Epidemiol (2001) 1.67
One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome. J Nerv Ment Dis (1993) 1.66
Effects of two types of brief intervention and readiness to change on alcohol use in hazardous drinkers. J Stud Alcohol (2001) 1.66
Expanded indications for laser-assisted balloon angioplasty in peripheral arterial disease. J Vasc Surg (1990) 1.62
Who provides gastrointestinal endoscopy in Canada? Can J Gastroenterol (2007) 1.58
An empirical investigation of the factor structure of the AUDIT. Psychol Assess (2000) 1.55
Anxiety and cognitive efficiency: differential modulation of transient and sustained neural activity during a working memory task. Cogn Affect Behav Neurosci (2008) 1.55
Relationship of Bacillus subtilis clades associated with strains 168 and W23: a proposal for Bacillus subtilis subsp. subtilis subsp. nov. and Bacillus subtilis subsp. spizizenii subsp. nov. Int J Syst Bacteriol (1999) 1.51
Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects. Gastroenterology (2001) 1.50
Cost effectiveness of vaccination strategies in adults without a history of chickenpox. Am J Med (2000) 1.49
Subcutaneous fluid administration in elderly subjects: validation of an under-used technique. J Am Geriatr Soc (1991) 1.49
Physician weight loss advice and patient weight loss behavior change: a literature review and meta-analysis of survey data. Int J Obes (Lond) (2012) 1.49
Clinical importance of provider-reported HIV symptoms compared with patient-report. Med Care (2001) 1.46
Activation of multiple interleukin-1beta converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J Biol Chem (1997) 1.46
Focused antithrombotic therapy: novel anti-platelet salicylates with reduced ulcerogenic potential and higher first-pass detoxification than aspirin in rats. J Lab Clin Med (1998) 1.44
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
A failure to communicate: patients with cerebral aneurysms and vascular neurosurgeons. J Neurol Neurosurg Psychiatry (2005) 1.44
Management of asymptomatic gallstones in the diabetic patient. A decision analysis. Ann Intern Med (1988) 1.40
Restriction fragment length polymorphisms associated with water use efficiency in tomato. Science (1989) 1.39
Costs of managing Helicobacter pylori-infected ulcer patients after initial therapy. Helicobacter (2001) 1.39
Sunscreens: are Australians getting the good oil? Aust N Z J Med (1998) 1.39
Prescriptions, practitioners and pharmacists. Med J Aust (1998) 1.39
P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions. EMBO J (2001) 1.35
The relation between health status changes and patient satisfaction in older hospitalized medical patients. J Gen Intern Med (1998) 1.35
Factor structure of the SOCRATES in a sample of primary care patients. Addict Behav (2000) 1.32
Does self-pollination provide reproductive assurance in Aquilegia canadensis (Ranunculaceae)? Am J Bot (1998) 1.30
Sociodemographic differences in early access to liver transplantation services. Am J Transplant (2009) 1.30
Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma. J Nucl Med (1998) 1.29
Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease. Eur J Clin Pharmacol (1982) 1.27
Autonomic function and human immunodeficiency virus infection. Neurology (1990) 1.26
Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. J Pharmacol Exp Ther (1994) 1.25
State of newly synthesized HeLa DNA. Nature (1969) 1.24
The onset of HIV infection in the Leningrad region of Russia: a focus on drug and alcohol dependence. HIV Med (2004) 1.24
Biodistribution, kinetics, and efficacy of highly phosphorylated and non-phosphorylated beta-glucuronidase in the murine model of mucopolysaccharidosis VII. J Biol Chem (2001) 1.23
Rates and predictors of hepatitis C virus treatment in HCV-HIV-coinfected subjects. Aliment Pharmacol Ther (2006) 1.23
The relationship between clinical assessments of nutritional status and adverse outcomes in older hospitalized medical patients. J Am Geriatr Soc (1999) 1.22
Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut (2005) 1.22
Veterans aging cohort three-site study (VACS 3): overview and description. J Clin Epidemiol (2001) 1.22
Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab (1997) 1.20
Multidisciplinary case conference reviews: improving outcomes for nursing home residents, carers and health professionals. Pharm World Sci (2001) 1.17
Nanotechnology, cosmetics and the skin: is there a health risk? Skin Pharmacol Physiol (2008) 1.16
First isolation of Cryptococcus neoformans var. gattii, serotype C, from the environment in Colombia. Med Mycol (1998) 1.16
Accuracy of administrative health data for the diagnosis of upper gastrointestinal diseases. Surg Endosc (2007) 1.13
Neuropeptide amidation in Drosophila: separate genes encode the two enzymes catalyzing amidation. J Neurosci (1997) 1.11
Quantitative light microscopic detection of Enterocytozoon bieneusi in stool specimens: a longitudinal study of human immunodeficiency virus-infected microsporidiosis patients. J Clin Microbiol (1996) 1.11
Self-restraint: a review of etiology and applications in mentally retarded adults with self-injury. Res Dev Disabil (1991) 1.10
Enzyme-linked immunosorbent assay spot detection of interferon-gamma and interleukin 5-producing cells as a predictive marker for renal allograft failure. Transplantation (1998) 1.10
Association of hypocholesterolaemia with hepatitis C virus infection in HIV-infected people. HIV Med (2004) 1.10
Alcohol abuse among patients with and without HIV infection attending public clinics in western Kenya. East Afr Med J (2004) 1.09
Development and characterization of a hemolytic assay for mouse C4. J Immunol Methods (1980) 1.09
Masking author identity in peer review: what factors influence masking success? PEER Investigators. JAMA (1998) 1.09
A developmental study of girls with trisomy X. Am J Hum Genet (1975) 1.08
Disappearance kinetics of solutes from synovial fluid after intra-articular injection. Br J Clin Pharmacol (1994) 1.08
Determination of aspirin and its major metabolites in plasma by high-performance liquid chromatography without solvent extraction. J Chromatogr (1981) 1.08
Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts. Br J Dermatol (2009) 1.08
Incidence of respiratory viruses in patients with community-acquired pneumonia admitted to the intensive care unit: results from the Severe Influenza Pneumonia Surveillance (SIPS) project. Eur J Clin Microbiol Infect Dis (2012) 1.07
A rapid method for determination of acetylation phenotype using dapsone. Br J Clin Pharmacol (1984) 1.07
Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation. Eur J Immunol (1998) 1.07
Kinetics of toxic doses of paraquat and the effects of hemoperfusion in the dog. J Toxicol Clin Toxicol (1993) 1.06
Endovascular occlusion of a carotid pseudoaneurysm complicating deep neck space infection in a child. Case report. J Neurosurg (1999) 1.06
A survey of self-restraint, self-injury, and other maladaptive behaviors in an institutionalized retarded population. Res Dev Disabil (1989) 1.05
Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis (1994) 1.05
Effect of ethanol on cardiac single sodium channel gating. Forensic Sci Int (2006) 1.05
Construction of genetic linkage maps in maize and tomato using restriction fragment length polymorphisms. Theor Appl Genet (1986) 1.04
SRTR program-specific reports on outcomes: a guide for the new reader. Am J Transplant (2008) 1.02